ACVR2A and neoplasm: The subcutaneous tumor xenograft experiment revealed that, relative to the negative control (NC) group, tumor volume markedly escalated in the ACVR2A-inhibitor group but substantially diminished in the ACVR2A-mimic group (Fig. 2A).